A treasure trove of genetic data may hold the key to a revolution in drug development, but it offers no clues for building a business.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Regulators voted in new rules aimed at protecting investors considering investing in the nontraditional setup.
No matter how you cast your ballot in the presidential election last month, recent history suggests your vote counts for IPOs.
The offer would put an 83% premium on Soho’s Wednesday closing price and comes a year after it had to close off admissions in three cities.
One ring to rule them all… at least, Oura hopes so. On Thursday, it announced a new $200 million funding round.